Greenlane Holdings, Inc.

GNLN
About the company

Greenlane Holdings, Inc. focuses on the acquisition, staking, validator participation, and strategic deployment of digital assets. It operates as a Berachain ecosystem participant focused on supporting the development and operation of blockchain-based infrastructure, including assets and applications built on Berachain.

Country: United StatesPrice: $0.89Market Cap: $615,713

Investment snapshot

0%positive consensus
Scored 1d ago

Positive

0

BUY / PASS

Neutral / negative

3 / 13

NEUTRAL / FAIL

Median fair value

—

No comparable estimates

Models with upside

0 / 17

Positive margin of safety

Key risk

No clean pass — all 10 investors flag at least one cash flow criterion

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILNot rankedFAILFAILFAILFAILFAILFAILFAILFAILFAILNEUTRALFAILNEUTRALNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Financial Basis

TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Annual history · FY 2025

Latest source filing: 2026-08-14

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-06-30

Latest source filing: 2026-08-14

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Market data at 2026-11-01

Latest source filing: 2026-08-14

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-06-30 · Market data at 2026-11-01

Latest source filing: 2026-08-14

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-03-31

Score computed: 2026-11-14

TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-08-14

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-06-30

Latest source filing: 2026-08-14

Score computed: 2026-11-14

TTM ended 2026-06-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-08-14

Score computed: 2026-11-14

Where It Passes

    Where It Falls Short

    • Cash Flow0% pass✓ 1✗ 11▾

      No clean pass — all 10 investors flag at least one cash flow criterion

      Free Cash Flow Proxy$-85.2M
      ✗BuffettPositive and growing
      FCF Positive and Growing$-16.4M
      ✗LynchPositive and growing
      Operating Cash Flow$-16.3M
      ✗PiotroskiCFO > 0
      (CFO / Total Assets) vs ROACFO/Assets=-21.70%, ROA=-114.21%
      ✓PiotroskiCFO/Assets > ROA
      Price / (CFO / Shares)N/A (negative CFPS)
      ✗Dreman< 8x
      P/E or FCF YieldFCF Yield=-2656.8%
      ✗PabraiP/E < 15 or FCF Yield > 10%
      FCF Positive0/8 years FCF positive
      ✗MarksPositive FCF in majority of recent years
      (OCF - CapEx) / Market Cap-246.2%
      ✗Ackman>= 4%
      Price / FCF per ShareN/A (negative FCF)
      ✗Ackman<= 25
      Positive Operating Cash Flow frequency0/8 years positive
      ✗SleepPositive OCF in >= 70% of available years
      Operating Cash Flow - Capital Expenditures$-16.4M
      ✗Neff> $0 (app proxy for a strong fundamental case)
      (Operating cash flow - capex) / market capitalization-2656.76%; #4447/4519 (top 98.4%)
      ✗OshaughnessyTop 10% of eligible cross-section
    • Growth0% pass✓ 1✗ 12▾

      No clean pass — all 8 investors flag at least one growth criterion

      EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)
      ✗Graham>= 33% growth
      Basic earnings-growth PEG (dividends excluded)
      ✗Lynch< 1.0 (ideally < 0.5)
      3-5 Year EPS CAGR
      ✗Lynch15-30% (Fast Grower); > 0% to pass
      Inventory Growth vs Revenue Growth
      ✗LynchInventory growth < Revenue growth
      EPS Growth Direction$-0.96 (2019) -> $-11.42 (2025)
      ✗DremanPositive over recent years
      EPS CAGR
      ✗Dreman> 5% annualized
      Positive Net Income Frequency0/8 years positive
      ✗MarksPositive net income in >= 7 of last 10 years
      3yr Median Revenue Growth-67.2%
      ✗Ackman>= 5%
      Positive EPS Growth Frequency3/5 years with positive EPS growth
      ✓AckmanPositive EPS growth in >= 3 of last 5 years
      5-Year EPS CAGR
      ✗Templeton> 0% (5-year EPS CAGR)
      Revenue growth vs. gross and operating margin trendgross margin 27.3% -> -286.2%, operating margin -39.9% -> -1245.6%
      ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
      5-year Revenue CAGR-49.9%
      ✗SleepCAGR > 7%
      3-5 Year Diluted EPS CAGR
      ✗Neff7%-20% annualized
    • Verdicts0% pass✗ 13▾

      Split decision: 13 FAIL · 3 NEUTRAL

      Overall verdict
      ✗GrahamFAIL (2/9)✗BuffettFAIL (0/9)✗LynchFAIL (0/7)•GreenblattNot ranked✗PiotroskiFAIL (F-Score 3)✗DremanFAIL (2/11)✗MungerFAIL (0/4)✗PabraiFAIL (1/3)✗AkreFAIL (1/6)✗MarksFAIL (1/5)✗AckmanFAIL (2/9)✗TempletonFAIL (3/8)✗SleepFAIL (1/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (0/6)•SchlossNEUTRAL (4/7)•OshaughnessyNEUTRAL (Not ranked)
    • Profitability6% pass✓ 2✗ 33▾

      15 of 16 flag GNLN's profitability — Graham, Buffett, Lynch +12 more

      Positive EPS (10 years)0/9 years positive
      ✗GrahamPositive EPS every year for 10 years
      EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)
      ✗Graham>= 33% growth
      Net Income Positive (10+ years)0/9 years positive
      ✗BuffettPositive every year for 10+ years
      ROE (up to 5-year arithmetic mean)-228.4%
      ✗Buffett> 15% arithmetic mean (app rule)
      Operating Margin (10-yr trend)-1245.6% (latest)
      ✗BuffettStable or rising over 10 years
      Free Cash Flow Proxy$-85.2M
      ✗BuffettPositive and growing
      Earnings Variance (10-yr CoV)N/A (negative mean EPS)
      ✗BuffettCoV < 0.3
      Retained Earnings Effectiveness
      ✗Buffett$1 retained -> > $1 market value created
      Basic earnings-growth PEG (dividends excluded)
      ✗Lynch< 1.0 (ideally < 0.5)
      3-5 Year EPS CAGR
      ✗Lynch15-30% (Fast Grower); > 0% to pass
      ROE-477.5%
      ✗Lynch> 15%
      EBIT / Enterprise ValueN/A (EV <= 0)
      ✗Greenblatt> 10%
      Earnings Yield + ROC AssessmentEY=N/A (EV <= 0), ROC=N/A (invested capital <= 0)
      ✗GreenblattBoth EY > 10% and ROC > 25%
      Net Income / Total Assets-114.21%
      ✗PiotroskiROA > 0
      ROA Change YoY-61.61% -> -114.21% (delta: -52.60%)
      ✗PiotroskiCurrent ROA > Prior ROA
      (CFO / Total Assets) vs ROACFO/Assets=-21.70%, ROA=-114.21%
      ✓PiotroskiCFO/Assets > ROA
      Gross Margin Change YoY47.3% -> -286.2%
      ✗PiotroskiImproved YoY
      Pre-Tax Income / Revenue-4624.8%
      ✗Dreman>= 8%
      Net Income / Shareholders' Equity-477.5%
      ✗Dreman> 12%
      Margin of SafetyP/B=0.1x
      ✓PabraiP/B < 1.5 or P/E < 15
      Return on Equity-229.9% (3-yr avg)
      ✗AkreROE > 20% (3-year avg)
      Discount to Intrinsic ValueN/A (negative normalized EPS)
      ✗Marks>= 20% below intrinsic value
      Positive Net Income Frequency0/8 years positive
      ✗MarksPositive net income in >= 7 of last 10 years
      Operating Income / Revenue-2151.4%
      ✗Ackman>= 15%
      Net Income / Shareholders Equity-477.5%
      ✗Ackman>= 15%
      5-Year EPS CAGR
      ✗Templeton> 0% (5-year EPS CAGR)
      Operating Margin Trend-39.9% (2023) -> -1245.6% (2025)
      ✗TempletonNon-negative operating-margin trend over 3 years
      Revenue growth vs. gross and operating margin trendgross margin 27.3% -> -286.2%, operating margin -39.9% -> -1245.6%
      ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
      Net income / market capitalization-19764.24%; #6262/6340 (top 98.8%)
      ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
      Gross profit / total assets-40.40%; #3678/3702 (top 99.4%)
      ✗AsnessTop 30% of eligible cross-section
      Net income / positive book equity-477.54%; #5068/5226 (top 97.0%)
      ✗AsnessTop 30% of eligible cross-section
      Negative 5-year standard deviation of ROA-0.5915; #5042/5884 (top 85.7%)
      ✗AsnessTop 30% of eligible cross-section
      3-5 Year Diluted EPS CAGR
      ✗Neff7%-20% annualized
      Positive Diluted-EPS Years0/7 years positive
      ✗Schloss>= 70% positive over 5-10 observed years (app rule)
    • Debt & Leverage8% pass✓ 3✗ 12▾

      11 of 12 flag GNLN's debt & leverage — Graham, Buffett, Lynch +8 more

      LT Debt vs Net Current Assets
      ✗GrahamLT Debt <= Net Current Assets
      Debt/Equity & Interest Coverage
      ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
      Total Debt / Equity
      ✗Lynch< 0.33
      Cash - Long-term Debt
      ✗LynchPositive preferred
      LT Debt / Total Assets Change26.80% -> 0.00%
      ✓PiotroskiDecreased YoY
      Current Assets / Current Liabilities2.36
      ✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)
      Total Debt / Shareholders' Equity
      ✗Dreman< 0.8✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00x
      Debt Levels
      ✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3
      Interest Coverage & Debt/EBITDAIC=-507.0x, D/EBITDA=N/A
      ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
      Total Debt / Shareholders Equity
      ✗Ackman<= 1.0
      Negative debt-to-equity (higher means less debt)
      ✗AsnessTop 30% of eligible cross-section
    • Valuation8% pass✓ 9✗ 19▾

      12 of 13 flag GNLN's valuation — Graham, Lynch, Greenblatt +9 more

      Price / 3-yr avg EPS
      ✗Graham<= 15x
      Price-to-Book Ratio0.1x
      ✓Graham<= 1.5x
      P/E x P/B
      ✗Graham<= 22.5
      Basic earnings-growth PEG (dividends excluded)
      ✗Lynch< 1.0 (ideally < 0.5)
      EBIT / Enterprise ValueN/A (EV <= 0)
      ✗Greenblatt> 10%
      Earnings Yield + ROC AssessmentEY=N/A (EV <= 0), ROC=N/A (invested capital <= 0)
      ✗GreenblattBoth EY > 10% and ROC > 25%
      Price / EPS
      ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
      Price / (CFO / Shares)N/A (negative CFPS)
      ✗Dreman< 8x
      Price / Book Value per Share0.1x
      ✓Dreman< 1.2x✓Templeton< 1.5x✓SchlossP/B <= 0.80x (app cutoff)
      Valuation ReasonablenessOE Yield=-1281.9%
      ✗MungerP/E < 25 or Owner Earnings Yield > 5%
      P/E or FCF YieldFCF Yield=-2656.8%
      ✗PabraiP/E < 15 or FCF Yield > 10%
      P/B or P/E vs. Historical AverageP/B=0.1x
      ✓MarksP/E < 15 or P/B < 2.0
      Discount to Intrinsic ValueN/A (negative normalized EPS)
      ✗Marks>= 20% below intrinsic value
      Price / FCF per ShareN/A (negative FCF)
      ✗Ackman<= 25
      Price vs. Trailing Low100% of trailing low ($0.89)
      ✓Templeton<= 120% of trailing low (certified split-adjusted live window)
      Net income / market capitalization-19764.24%; #6262/6340 (top 98.8%)
      ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
      Positive book equity / market capitalization+41.3878; #90/6449 (top 1.4%)
      ✓AsnessTop 30% of eligible cross-section
      Price / Diluted EPS
      ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
      (EPS CAGR % + Dividend Yield %) / P/E
      ✗Neff> 0.7 (Neff's published traditional edge)
      Price / Tangible Book Value per Share0.10x
      ✓SchlossP/TBV <= 1.00x (app cutoff)
      Book Value per Share Change+618.5%
      ✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
      Revenue / market capitalization+4.2682; #616/5247 (top 11.7%)
      ✗OshaughnessyTop 10% of eligible cross-section
      (Operating cash flow - capex) / market capitalization-2656.76%; #4447/4519 (top 98.4%)
      ✗OshaughnessyTop 10% of eligible cross-section
      Trailing six-month price return through the evaluation date-69.73%; #5651/6202 (top 91.1%)
      ✗OshaughnessyTop 10% of eligible cross-section
    • Efficiency25% pass✓ 3✗ 8▾

      6 of 8 flag GNLN's efficiency — Buffett, Greenblatt, Piotroski +3 more

      Current Ratio2.36
      ✓Graham>= 2.0
      ROIC (3-5 yr avg)-102.6%
      ✗Buffett> 10%
      ROIC - WACC-112.6%
      ✗BuffettPositive (WACC = 10%)
      EBIT / (NWC + Net Fixed Assets)N/A (invested capital <= 0)
      ✗Greenblatt> 25%
      Current Ratio Change YoY1.07 -> 5.01
      ✓PiotroskiIncreased YoY
      Revenue / Total Assets Change YoY0.46x -> 0.06x
      ✗PiotroskiImproved YoY
      Current Assets / Current Liabilities2.36
      ✓Dreman> 1.5
      Return on Invested Capital
      ✗Munger> 15%
      ROIC (high and growing)FY2023: ROIC=-111.9%; FY2024: ROIC=-66.2%; FY2025: ROIC=unavailable
      ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
      Reinvestment Rate x ROIC
      ✗AkreReinvestment Rate * ROIC > 10%
      ROIC (5-year)0/4 years above 12% (latest -66.2%)
      ✗SleepROIC > 12% in a majority of years

    Business & financials

    Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

    Company Profile

    Industry: Wholesale
    SIC Sector: Durable Goods Wholesale
    Size: Micro Cap($615,713)
    Revenue: $4.4M-67.2% YoY
    Net Income: $85.6M-385.1% YoY

    Financial Snapshot

    Operating Margin-1245.6%
    Return on Equity-126.1%
    Debt / Equity--
    Current Ratio5.01
    EPS (Diluted)$-11.42

    Shareholder Return

    Fiscal 2025

    Share retirement not available for this company.

    Buybacks
    —
    Dividends
    —

    Company Financials

    Latest TTM and quarters alongside annual years

    TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

    The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

    MetricTTM · 2026-06-30

    2025-07-01 – 2026-06-30

    Sources · derived quarter values

    Derived from cumulative filings: operating cash flow, depreciation amortization, capex, revenue, net income, operating income, gross profit, ebit, pre tax income, interest expense.

    Q2 FY 2026

    2026-04-01 – 2026-06-30

    Sources · derived quarter values

    Derived from cumulative filings: operating cash flow, depreciation amortization.

    Q1 FY 2026

    2026-01-01 – 2026-03-31

    Sources
    FY 2025
    Sources
    • 10-K · 2026-03-31
    FY 2024
    Sources
    • 10-K · 2025-03-21
    FY 2023
    Sources
    • 10-K · 2024-07-19
    FY 2022
    Sources
    • 10-K · 2023-03-31
    FY 2021
    Sources
    • 10-K · 2022-03-31
    Market Cap$615.7Kcurrent----$88.7Mest.$10.3Best.$128.6Best.$2.4Test.$388.2Test.
    Revenue$2.6M↓67%$82.0K↓90%$448.0K↓70%$4.4M↓67%$13.3M↓80%$65.4M↓52%$137.1M↓17%$166.1M
    Operating Income-$56.5M↓411%-$3.3M↓1%-$5.6M↓60%-$54.2M↓359%-$11.8M↑55%-$26.1M↑86%-$184.1M↓249%-$52.7M
    Net Income-$121.7M↓520%-$24.8M↓672%-$18.4M↓375%-$85.6M↓385%-$17.6M↑45%-$32.2M↑81%-$169.5M↓454%-$30.6M
    EPS (Diluted)--$-6.06↓91%$-4.49↓1303%$-11.42↑22%$-14.56↓78%$-8.16↑47%$-15.37↓1846%$-0.79
    Gross Margin-492.4%↓974%39.0%↑15276%48.4%↓1%-286.2%↓705%47.3%↑74%27.3%↑50%18.2%↓11%20.4%
    Operating Margin-2151.4%↓1446%-4004.9%↓869%-1243.8%↓426%-1245.6%↓1300%-89.0%↓123%-39.9%↑70%-134.3%↓323%-31.7%
    ROE-477.5%↓389%——-126.1%↑54%-274.3%↑5%-289.2%↑33%-434.9%↓2382%-17.5%
    Total Debt--------$7.7M↑5%$7.3M↓55%$16.2M↓27%$22.2M
    Shareholders' Equity$25.5M↑27%$25.5M↑27%$50.1M↑115%$67.9M↑955%$6.4M↓42%$11.1M↓71%$39.0M↓78%$174.5M
    Current Ratio2.36↓1%2.36↓1%3.25↑45%5.01↑369%1.07↓6%1.14↓47%2.15↑22%1.76
    Debt / Equity————1.19↑82%0.65↑57%0.42↑227%0.13
    Operating Cash Flow-$15.5M↓51%-$2.3M↓467%-$4.8M↓40%-$16.3M↓141%-$6.8M↓276%-$1.8M↑93%-$26.4M↑29%-$37.3M
    Free Cash Flow-------$16.4M↓134%-$7.0M↓150%-$2.8M↑90%-$29.2M↑30%-$41.7M

    Score history

    Historical Score Timeline

    Industry peers

    Industry Peers

    Similar companies in Wholesale

    GNLN vs Peers — Financial Grading

    Revenue$4.4MBottom 25%
    Net Income$85.6MBottom 25%
    ROE-126.1%Bottom 25%
    D/E—
    Op. Margin-1245.6%Bottom 25%
    Curr. Ratio5.01Top 25%
    CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
    MCKESSON CORPMCK$127.3B$1102.81$403.4B$4.8B-219.2%-3.001.5%0.852/95/94/70/3F-Score 61/11
    W.W. GRAINGER, INC.GWW$69.7B$1489.30$17.9B$1.7B45.7%0.6713.9%2.834/96/94/71/3F-Score 65/11
    CARDINAL HEALTH INCCAH$65.0B$281.10$254.2B$1.7B-59.5%-3.081.0%0.882/93/93/70/3F-Score 81/11
    SYSCO CORPSYY$38.0B$77.10$81.4B$1.8B99.9%—3.8%1.213/95/95/71/3F-Score 42/11
    RELIANCE, INC.RS$21.8B$427.33$14.3B$739.4M10.3%0.207.1%4.884/97/93/70/3F-Score 55/11
    WATSCO INCWSO$12.8B$308.46$7.2B$497.0M17.9%0.1710.0%4.125/97/94/71/3F-Score 68/11
    APPLIED INDUSTRIAL TECHNOLOGIES INCAIT$10.9B$297.60$4.6B$393.0M21.3%0.3110.9%3.326/95/94/71/3F-Score 57/11
    POOL CORPPOOL$7.7B$216.20$5.3B$406.4M34.3%1.0111.0%2.243/96/94/71/3F-Score 56/11